02507nam 2200541Ia 450 991013985800332120170816115955.01-282-30608-197866123060821-4443-1676-11-4443-1677-X(CKB)1000000000806849(EBL)547179(OCoLC)469082153(SSID)ssj0000300369(PQKBManifestationID)11238466(PQKBTitleCode)TC0000300369(PQKBWorkID)10251921(PQKB)10853003(MiAaPQ)EBC547179(PPN)198098510(EXLCZ)99100000000080684920090306d2009 uy 0engur|n|---|||||txtccrAn introduction to pharmacovigilance /Patrick WallerChichester, UK ;Hoboken, NJ Wiley-Blackwell20091 online resource (122 p.)Includes index.1-4051-9471-5 Cover; Contents; Acknowledgements; Foreword; Preface; Chapter 1 What is pharmacovigilance and how has it developed?; Chapter 2 Basic concepts; Chapter 3 Types and sources of data; Chapter 4 The process of pharmacovigilance; Chapter 5 Regulatory aspects of pharmacovigilance; Chapter 6 International collaboration; Chapter 7 Ethical and societal considerations; Chapter 8 Future directions; Chapter 9 Learning more about pharmacovigilance; Glossary; IndexPharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems. This introductory guide is designed to aid the rapid understanding of the key principles of pharmacovigilance. Packed full of examples illustrating drug safety issues it not only covers the processes involved, but the regulatory aspects and ethical and societal considerations of pharmacovigilance. Covering the basics step-by-step, this book is perfect for beginners and is essential reading for those new to drug safety depDrugsSide effectsPharmacoepidemiologyDrugsSide effects.Pharmacoepidemiology.615.7042Waller Patrick521105MiAaPQMiAaPQMiAaPQBOOK9910139858003321Introduction to pharmacovigilance832547UNINA